Morris A. Blajchman, MD, FRCP(C)

Dr. M.A. Blajchman qualified as a physician in 1964 at McGill University in Montreal, Canada. His post-graduate training was in internal medicine at the University of Pennsylvania, and in hematology at the Royal Postgraduate Medical School in London, England. Dr. Blajchman has been a member of the Faculty at McMaster University since 1970, where he is currently Emeritus Professor in both the Departments of Medicine and Pathology. He is also currently Medical Director of the Southern Ontario Centres of Canadian Blood Services.

In September 2007 the National Heart, Lung, and Blood Institute (NHLBI) appointed Dr. Blajchman Chairman of the Transfusion Medicine and Hemostasis Clinical Trials Network (TMH CTN). The Network is comprised of seventeen clinical centers and a data coordinating center. The goal of the TMH CTN is to design and perform multi-center clinical trials comparing management strategies of potential benefit for children and adults with hemostatic disorders and to evaluate novel and existing blood component therapies for the treatment of hematologic disorders.

Dr. Blajchman has published or has in press over 360 articles relating to both Transfusion Medicine and hemostasis. He is the founding and current Editor of the journal Transfusion Medicine Reviews, which in January 2008 began its twenty-second year of publication. Dr. Blajchman in his more than 30-year career has received many awards and honors. These include: in 2003, a Lifetime Achievement Award from Canadian Blood Services; in 2004, the Foundation Lectureship for the Royal College of Pathologists, London, England, and the Emily Cooley Award and Lectureship presented at the 2004 Annual Meeting of the AABB.